# OCL 500 Treatment of Women With Symptomatic Uterine Fibroids

> **NCT03427671** · NA · COMPLETED · sponsor: **IMBiotechnologies Ltd.** · enrollment: 12 (actual)

## Conditions studied

- Uterine Fibroid
- Myoma
- Leiomyoma

## Interventions

- **DEVICE:** Occlusin 500 Microspheres

## Key facts

- **NCT ID:** NCT03427671
- **Lead sponsor:** IMBiotechnologies Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-17
- **Primary completion:** 2019-09-03
- **Final completion:** 2019-09-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03427671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03427671, "OCL 500 Treatment of Women With Symptomatic Uterine Fibroids". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03427671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*